ARJ_Specialty_Infusion_Pharmacy_Nursing_Patient

ARJ News &
Media Highlights

Top awards and stories of home infusion provider

Check out The Dose for the latest ARJ news and events.
Browse ARJ’s Media Archives to see additional coverage.

 

ARJ Begins Bamlanivimab Infusions for COVID-19 Patients

Jan. 7, 2021, Business Wire

ARJ Infusion Services will dispense and administer bamlanivimab (Eli Lilly), a monoclonal antibody drug to treat COVID-19. ARJ will dispense treatments to eligible high-risk individuals residing or working in assisted living and long-term care facilities.

Media Contact 💬

Joshua McBride
866-451-8804

Email Josh
Browse ARJ's Media Archives to see additional coverage.
2020
2019
2018
2017
2016
2015
ARJ_Infusion_Top_Infusion_Services_Patient_Satisfaction_Nationwide
ARJ ranks among the top 10% nationwide in home infusion care »
ARJ_Specialty_Infusion_Pharmacy_Nursing_Patient_IVIg
Learn how IVIg therapy helped this road warrior find relief »
ARJ_Specialty_Infusion_Pharmacy_Nursing_Patient_Financial_Assistance
ARJ secured over $5 million in financial assistance for patients in 2019 »
ARJ_Infusion_Services_Online_Bill_Pay_Convenient_Chronic_Conditions
Manage your bills or make a payment through ARJ Online Bill Pay »
ARJ_Patient_Services_Financial_Assistance_Support_Infusion
We're experts at helping children and adults with chronic conditions »
ARJ_Specialty_Infusion_Pharmacy_Nursing_Patient_Communications
Do you have questions about infusion therapy? We're here for you! »
Menu